Ian Nisbet (PhD, MAICD)


Ian has over 30 years of drug development, business development and general management experience in the local and international biotechnology sector. He is a founder and partner in the biotechnology consulting company Afandin Pty Ltd. He has previously been CEO/MD of Xenome Ltd and Meditech Research Ltd and held senior management positions at Millennium Pharmaceuticals Inc, ChemGenex Pharmaceuticals Ltd and CSL Ltd. Ian currently serves as Chairman of Verva Pharmaceuticals Ltd and vivoPharm Pty Ltd, a non-Executive Director of Velacor Pty Ltd and Deputy Director (Commercialisation) at the Australian Institute for Bioengineering and Nanotechnology (AIBN).